Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2018 1
2019 1
2020 2
2021 1
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
Cost-Effectiveness Analysis of Sequential Biologic Therapy with Ixekizumab Versus Secukinumab in the Treatment of Active Psoriatic Arthritis with Concomitant Moderate-to-Severe Psoriasis in the UK.
Schweikert B, Malmberg C, Åkerborg Ö, Kumar G, Nott D, Kiri S, Sapin C, Hartz S. Schweikert B, et al. Among authors: kiri s. Pharmacoecon Open. 2020 Dec;4(4):635-648. doi: 10.1007/s41669-020-00202-1. Pharmacoecon Open. 2020. PMID: 32166657 Free PMC article.
Efficacy of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: A Systematic Literature Review and a Network Meta-Analysis.
Armstrong A, Fahrbach K, Leonardi C, Augustin M, Neupane B, Kazmierska P, Betts M, Freitag A, Kiri S, Taieb V, Slim M, Gomez NN, Warren RB. Armstrong A, et al. Among authors: kiri s. Dermatol Ther (Heidelb). 2022 Aug;12(8):1777-1792. doi: 10.1007/s13555-022-00760-8. Epub 2022 Jul 7. Dermatol Ther (Heidelb). 2022. PMID: 35798920 Free PMC article.